Gentronix, Part of Scantox Group Employee Directory
Research ServicesEngland, United Kingdom51-200 Employees
Gentronix, now part of the Scantox Group, operates as a contract research organization focused on predictive toxicology for global chemical sectors. For more than twenty years it has supported development programs by enabling early identification of genotoxic hazards and robust chemical safety assessments. Its genetic toxicology offering covers the spectrum from initial screening to regulatory submission, backed by a proprietary genomic safety platform and exclusive rights to a transgenic rodent gene mutation assay and to DuplexSeq Mutagenesis Assays, with additional Ames testing and OECD-regulated in vitro and in vivo assays delivered from GLP-compliant laboratories in Alderley Park, England. The company serves pharmaceutical, biotech, agrochemical, and consumer product industries worldwide. In 2024, Scantox Group acquired Gentronix, expanding its nonclinical safety capabilities.
1-888-653-2347 
support@leadiq.com 
